Similarly, a recent real-world study in CKD stage G3–G4 found that, compared to other vitamin D therapies (active vitamin D and nutritional vitamin D), ERC significantly reduced PTH and resulted in greater increases in 25(OH)D levels, without increases in serum calcium seen in patients treated with active vitamin D [62]. Here, PTH is linked to chronic kidney disease.